Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRTAP21-4P (Keratin associated protein 21-4, pseudogene) is classified as a **pseudogene** within the keratin-associated protein (KAP) family[4]. The KAP family forms the matrix surrounding keratin intermediate filaments in hair and wool, contributing to their structure and mechanical properties, but pseudogenes such as KRTAP21-4P are genetically disrupted and do not produce a functional protein[2][4][5]. Pseudogenes are DNA sequences similar to normal genes but typically **lack biological function** due to mutations like frameshifts or in-frame stop codons[2][5]. KRTAP21-4P is not considered a therapeutic target, as it does not encode a functional protein involved in disease or modifiable cellular processes[4]. Its presence is mainly of interest in studies on gene evolution and the structural genomics of the KAP family[2][5]. **Notes:** - The HGNC-approved symbol is KRTAP21-4P; "KAP21A" is an alias, and "KRTAP21P1" is a previous symbol[4]. - As a **pseudogene**, KRTAP21-4P is not druggable, does not have known disease associations, and does not serve as a therapeutic biomarker[4]. - There is nothing to suggest its use as a biomarker, safety concern, or its implication in any biological pathway or disease[4][2]. - Its main relevance is taxonomical and evolutionary, not functional or clinical[2][5]. **Summary:** KRTAP21-4P is a non-functional **pseudogene** belonging to the keratin-associated protein gene family; it does not produce a protein, is not a therapeutic target, and has no known biological or disease role[4][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin associated protein 21-4, pseudogene (KRTAP21-4P).